You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -326.3% | -136.4% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 31.7 | 14.9 |
| Price / Book value | 16.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 228.2% | 517.8% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -3.9% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-07-31 | 2.76 | -10.39 | -9.50p | -2.6 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 5.51 | -18.05 | -12.98p | -1.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 2.14 | -18.86 | -7.27p | -15.7 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 2.94 | -29.19 | -10.57p | -12.0 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 9.65 | -41.46 | -15.48p | -7.4 | 0.0 | n/a | n/a | 0.0% |
| Avacta triggers second milestone payment in AffyXell venture Sharecast News | 05 Jun |
|---|---|
| Avacta buys Belgium-based Coris Bioconcept for £7.4m Sharecast News | 01 Jun |
| Avacta doses first patient in US tumour treatment trial Sharecast News | 27 Apr |
| Second Milestone in AffyXell Joint Venture | 05-Jun-23 14:22 |
|---|---|
| Posting of Annual Report and Notice of AGM | 02-Jun-23 14:08 |
| Avacta acquires Coris Bioconcept | 01-Jun-23 15:03 |
| Block Listing Six Monthly Return | 27-Apr-23 15:51 |
| First Patient Dosed in the US in AVA6000 Phase 1 | 27-Apr-23 15:51 |